|
|
||||||||
a Geron Corporation, Menlo Park, California, USA;
b Department of Gene Expression and Development, Roslin Institute, Roslin Midlothian, United Kingdom
Key Words. Human embryonic stem cells • Human telomerase reverse transcriptase Telomerase • Immortalization • Differentiation
Correspondence: Chunhui Xu, Ph.D., Geron Corporation, 230 Constitution Drive, Menlo Park, California 94025, USA. Telephone: 650-473-7795; Fax: 650-473-7750; e-mail: cxu{at}geron.com
Human embryonic stem cells (hESCs) have the potential to generate multiple cell types and hold promise for future therapeutic applications. Although undifferentiated hESCs can proliferate indefinitely, hESC derivatives significantly downregulate telomerase and have limited replication potential. In this study we examine whether the replicative lifespan of hESC derivatives can be extended by ectopic expression of human telomerase reverse transcriptase (hTERT), the catalytic component of the telomerase complex. To this end, we have derived HEF1 cells, a fibroblast-like cell type, differentiated from hESCs. Infection of HEF1 cells with a retrovirus expressing hTERT extends their replicative capacity, resulting in immortal human HEF1-hTERT cells. HEF1-hTERT cells can be used to produce conditioned medium (CM) capable of supporting hESC growth under feeder-free conditions. Cultures maintained in HEF1-CM show characteristics similar to mouse embryonic fibroblast CM control cultures, including morphology, surface marker and transcription factor expression, telomerase activity, differentiation, and karyotypic stability. In addition, HEF1-hTERT cells have the capacity to differentiate into cells of the osteogenic lineage. These results suggest that immortalized cell lines can be generated from hESCs and that cells derived from hESCs can be used to support their own growth, creating a genotypically homogeneous system for the culture of hESCs.
This article has been cited by other articles:
![]() |
B. Greber, H. Lehrach, and J. Adjaye Fibroblast Growth Factor 2 Modulates Transforming Growth Factor {beta} Signaling in Mouse Embryonic Fibroblasts and Human ESCs (hESCs) to Support hESC Self-Renewal Stem Cells, February 1, 2007; 25(2): 455 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lian, E. Lye, K. Suan Yeo, E. Khia Way Tan, M. Salto-Tellez, T. M. Liu, N. Palanisamy, R. M. El Oakley, E. H. Lee, B. Lim, et al. Derivation of Clinically Compliant MSCs from CD105+, CD24- Differentiated Human ESCs Stem Cells, February 1, 2007; 25(2): 425 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Skottman and O. Hovatta Culture conditions for human embryonic stem cells. Reproduction, November 1, 2006; 132(5): 691 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gosens, G. L. Stelmack, G. Dueck, K. D. McNeill, A. Yamasaki, W. T. Gerthoffer, H. Unruh, A. S. Gounni, J. Zaagsma, and A. J Halayko Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L523 - L534. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Olivier, A. C. Rybicki, and E. E. Bouhassira Differentiation of Human Embryonic Stem Cells into Bipotent Mesenchymal Stem Cells Stem Cells, August 1, 2006; 24(8): 1914 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. POLAK and A. E. BISHOP Stem Cells and Tissue Engineering: Past, Present, and Future Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 352 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, Z. F. Fang, F. Jin, Y. Lu, H. Gai, and H. Z. Sheng Derivation and Growing Human Embryonic Stem Cells on Feeders Derived from Themselves Stem Cells, September 1, 2005; 23(9): 1221 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. LEV, I. KEHAT, and L. GEPSTEIN Differentiation Pathways in Human Embryonic Stem Cell-Derived Cardiomyocytes Ann. N.Y. Acad. Sci., June 1, 2005; 1047(1): 50 - 65. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
